Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LMOD+: A Comprehensive Multimodal Dataset and Benchmark for Developing and Evaluating Multimodal Large Language Models in Ophthalmology.

ACM transactions on computing for healthcare·2026
Same author

Masquerading disease of macular telangiectasia type 2 - MacTel Project Report No 11.

Ophthalmology. Retina·2026
Same author

Multi-omic analysis of deep learning-derived phenotypes links ophthalmic imaging to cardiovascular and neurological traits.

Nature cardiovascular research·2026
Same author

Choroidal vascularity across aging and the spectrum of age-related macular degeneration: an AI-based OCT study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Central Serous Chorioretinopathy: Etiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international·2026
Same author

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 34 Trials including 114,326 Individuals.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Oct 24, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K

Imaging endpoints for clinical trials in MacTel type 2.

Daniel Pauleikhoff1, Laurenz Pauleikhoff2, Emily Y Chew3

  • 1Department of Ophthalmology, St. Franziskus Hospital Muenster, Münster, Germany. dapauleikhoff@muenster.de.

Eye (London, England)
|August 14, 2021
PubMed
Summary

Macular Telangiectasia type 2 (MacTel) is a neurodegenerative disease. Quantifying photoreceptor loss using en face OCT is the most reliable method for evaluating treatment efficacy in clinical trials.

More Related Videos

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures
10:23

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures

Published on: December 14, 2019

9.5K
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.9K

Related Experiment Videos

Last Updated: Oct 24, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K
Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures
10:23

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures

Published on: December 14, 2019

9.5K
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.9K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Medical Imaging

Background:

  • Macular Telangiectasia type 2 (MacTel) is a bilateral neurodegenerative condition affecting Muller cells and photoreceptors.
  • Disease progression involves vascular abnormalities, retinal transparency loss, pigment redistribution, and central retinal thinning.
  • Photoreceptor loss extent, visualized via Optical Coherence Tomography (OCT), correlates with functional deficits, making its limitation a key therapeutic goal.

Purpose of the Study:

  • To review imaging techniques for MacTel assessment.
  • To discuss objective quantification of MacTel severity and its correlation with visual function.
  • To evaluate imaging endpoints for clinical treatment trials.

Main Methods:

  • Review of imaging modalities including fluorescein and OCT angiography, blue light reflectance, and multi-wavelength autofluorescence.
  • Analysis of Optical Coherence Tomography (OCT) for quantifying photoreceptor loss.
  • Correlation of imaging findings with functional measures like best-corrected visual acuity (BCVA) and microperimetry.

Main Results:

  • En face OCT provides precise and reproducible quantification of photoreceptor loss area.
  • Photoreceptor loss area measured by en face OCT shows a highly significant correlation with functional loss assessed by microperimetry.
  • This imaging endpoint is crucial for evaluating treatment efficacy in MacTel.

Conclusions:

  • En face OCT analysis of photoreceptor loss area is the most reliable imaging endpoint for MacTel treatment trials.
  • This quantitative imaging method is currently utilized in ongoing randomized clinical trials for MacTel.
  • Precise and reproducible outcome measures are essential for assessing therapeutic interventions in MacTel.